American Express, US0258161092

American Express clears new stress test hurdle, shares in focus among US card issuers

Published on 06/29/2026 at 15:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

American Express discloses 2026 Dodd-Frank Act stress test results for its U.S. bank unit. The NYSE-listed S&P 500 constituent shows capital ratios remaining above regulatory minimums under severe scenarios, drawing attention to its risk profile versus peers.

American Express, US0258161092, Illustration mit AI erstellt.
American Express, US0258161092, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 15:18.

American Express Company (US0258161092) has published its 2026 Dodd-Frank Act stress test results for American Express National Bank. The NYSE-listed S&P 500 constituent details capital ratios that remain above regulatory minimums even under severely adverse scenarios, according to the group’s June disclosure. American Express stress test results

What the stress test shows

In its 2026 Dodd-Frank Act stress test summary, American Express reports projected Common Equity Tier 1 (CET1) ratios that stay comfortably above the 4.5 percent regulatory minimum across modeled scenarios. The document outlines baseline, adverse and severely adverse macroeconomic paths, including rising unemployment and market volatility. Federal Reserve stress testing overview

The stress test results focus on the firm’s U.S. banking subsidiary, American Express National Bank, which houses a significant portion of its card-related lending activities. Under the severely adverse scenario, projected loan losses rise meaningfully, yet the capital metrics in the disclosure indicate the bank would still meet required buffers.

Analyst views and peer context

American Express trades on the NYSE under the ticker AXP and sits within the financials segment of the S&P 500 alongside card peers such as Visa and Mastercard. According to consensus data compiled by MarketScreener, a majority of analysts rate the stock at Buy or equivalent, with average 12-month price targets close to the recent market level. MarketScreener consensus on American Express

Recent market commentary from Reuters notes that large U.S. card issuers have generally shown resilient capital positions in regulatory stress exercises, though consumer credit normalization and higher funding costs remain key discussion points for investors. In that context, American Express’s disclosed stress test numbers provide additional visibility on the durability of its capital base.

Go deeper

All news and analysis on the American Express shares

Further headlines, price data and regulatory filings on American Express are available in the dedicated topic section and via the company’s investor relations page.

The product behind the stock

American Express generates most of its revenue from charge and credit card services aimed at premium consumer and business segments. Flagship offerings such as the American Express Platinum and Gold cards combine rewards, travel benefits and membership services, supporting spending volumes and fee income across its global network.

Where the stock trades today

American Express shares (US0258161092) trade on the NYSE under the ticker AXP, with the last quoted price at about 275 US dollars as of 2026-06-29, 14:50, according to recent data from Yahoo Finance.

Key data on the American Express shares

  • Company: American Express Company
  • ISIN: US0258161092
  • WKN: 850226
  • Ticker: AXP
  • Trading venue: NYSE
  • Price (as of 2026-06-29, 14:50): 275 USD
  • Market cap: around 196 billion USD (as of 2026-06-29)
  • Sector / industry: Financials / Consumer finance and card services
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on the American Express shares in social media

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell securities. Data and assessments are based on sources deemed reliable at the time of publication but may change without notice.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US0258161092 | AMERICAN EXPRESS | boerse | 69653451 | bgmi